Cellectar Biosciences Financials

$15.3 M

Mkt cap, 16-Feb-2018
Net income (Q1, 2017)(2.9 M)
EBIT (Q1, 2017)(2.8 M)
Cash, 31-Mar-201711.2 M

Market Value

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

R&D expense

6.9 m6 m5.2 m4.8 m

General and administrative expense

4.4 m3.7 m3.4 m4.7 m

Operating expense total

11.3 m9.7 m8.6 m9.4 m

EBIT

(12.4 m)(9.9 m)(8.8 m)(9.4 m)

Interest expense

9.3 k446.3 k8417.9 k

Interest income

7.9 k

Net Income

(10.8 m)(8.1 m)(5.5 m)(6.2 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

R&D expense

1.4 m1.5 m1.6 m1.4 m1.2 m1 m965.2 k1.3 m1.9 m

General and administrative expense

959.9 k802.8 k943.4 k817.7 k834.9 k961.3 k1.4 m1.2 m955.4 k

Operating expense total

2.3 m2.3 m2.6 m2.2 m2 m2 m2.3 m2.5 m2.8 m

EBIT

(2.5 m)(2.3 m)(2.6 m)(2.3 m)(2.1 m)(2 m)(2.3 m)(2.5 m)(2.8 m)

Interest expense

114 k253.1 k2 k4496175491.6 k3.1 k

Interest income

4496175491.6 k3.1 k

Net Income

(2.1 m)(505.7 k)(2.3 m)(2.3 m)(1.9 m)824.6 k(2.1 m)(2.3 m)(2.9 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.4 m9.4 m3.9 m11.4 m

Inventories

294.7 k220.6 k267.8 k693.6 k

Current Assets

2.8 m9.7 m4.2 m12.2 m

Goodwill

1.7 m1.7 m1.7 m1.7 m

Total Assets

6.8 m13.4 m7.6 m15.3 m

Accounts Payable

1.4 m

Short-term debt

450 k119.9 k243.6 k86.6 k

Current Liabilities

4.5 m2.2 m5.7 m1.6 m

Long-term debt

450 k

Non-Current Liabilities

593.2 k489 k243.5 k151.8 k

Total Debt

900 k86.6 k

Total Liabilities

5.1 m2.7 m5.9 m1.8 m

Additional Paid-in Capital

52.8 m69.9 m66.3 m83.5 m

Retained Earnings

(59.2 m)(64.6 m)(70.8 m)

Total Equity

1.6 m13.5 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0.1 x0 x

Financial Leverage

4.6 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

1.6 m11.6 m7 m4.8 m2.5 m1.9 m7.9 m5.6 m11.2 m

Current Assets

2 m11.9 m7.3 m5 m3 m2.2 m8.1 m6.1 m12.2 m

Goodwill

1.7 m1.7 m1.7 m1.7 m1.7 m1.7 m1.7 m1.7 m1.7 m

Total Assets

5.9 m15.7 m10.9 m8.6 m6.5 m5.6 m11.4 m9.3 m15.3 m

Accounts Payable

1.2 m1.1 m824.2 k712.2 k579.8 k608.7 k816.8 k1.1 m1.2 m

Short-term debt

41.3 k103.3 k180.4 k240.8 k242.4 k244.8 k208.9 k147.9 k

Current Liabilities

4.1 m2.1 m5.9 m5.8 m5.5 m2.8 m1.4 m1.4 m1.4 m

Non-Current Liabilities

4.4 m505.1 k427.8 k367 k305.8 k180.8 k154.9 k153.8 k149.9 k

Additional Paid-in Capital

53.5 m69.7 m66 m66.1 m66.2 m66.4 m75.7 m75.9 m87.4 m

Retained Earnings

(65.9 m)(73.7 m)

Total Equity

(2.5 m)13.1 m2.4 m680.2 k2.6 m9.8 m7.7 m13.7 m

Financial Leverage

-2.3 x1.2 x3.6 x9.5 x2.2 x1.2 x1.2 x1.1 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(10.8 m)(8.1 m)(5.5 m)(6.2 m)

Depreciation and Amortization

424.8 k367.2 k362.5 k356.7 k

Inventories

48.1 k74.1 k(8.6 k)(464.4 k)

Short-term Borrowings

(617.5 k)

Cash From Financing Activities

5 m15.9 m2.7 m15.9 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.1 m)(505.7 k)(2.3 m)(2.3 m)(1.9 m)824.6 k(2.1 m)(2.3 m)(2.9 m)

Ratios

Y, 2017

Financial Leverage

1.1 x